Livzon pharmaceutical group continues A share repurchases

Livzon Pharmaceutical Group Inc. submitted its Next Day Disclosure Return on September 16, 2025, detailing changes in its issued H shares. The opening and closing balance of issued H shares (excluding treasury shares) as of September 15 and September 16, 2025, remained constant at 299,807,117. There were no changes in treasury shares for H shares during this period.

The report also highlighted share repurchase activities for its A shares, which are listed on the Shenzhen Stock Exchange. On September 16, 2025, the company repurchased 92,100 A shares on another stock exchange. These repurchases occurred at prices ranging from 39.78 yuan to 40.34 yuan, with an aggregate price paid of 3,691,409 yuan. These repurchased shares are yet to be cancelled.

The company has been consistently repurchasing A shares, with transactions dating back to December 2024 and continuing through August and September 2025. The detailed disclosures show daily repurchases varying in volume and price, indicating a sustained share buyback program. For instance, on September 15, 2025, 74,400 A shares were repurchased at 40.32 yuan.